Trials / Conditions / High-risk Percutaneous Coronary Intervention

High-risk Percutaneous Coronary Intervention

9 registered clinical trials studyying High-risk Percutaneous Coronary Intervention — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI) NCT07296744	Supira Medical	N/A
Completed	Early Feasibility Study of the Supira System in Patients Undergoing HRPCI NCT06087575	Supira Medical	N/A
Completed	VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS) NCT06132568	Boston Scientific Corporation	N/A
Completed	Magenta Elevate™ EFS in High-Risk PCI Patients NCT05727059	Magenta Medical Ltd.	N/A
Enrolling By Invitation	Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol NCT05334784	Abiomed Inc.	N/A
Active Not Recruiting	Magenta Elevate™ First-in-Human Clinical Study in High-Risk PCI Patients NCT06099548	Magenta Medical Ltd.	N/A
Active Not Recruiting	Impella ECP Early Feasibility Study NCT04477603	Abiomed Inc.	N/A
Unknown	Protect Kidney Trial NCT04321148	Heinrich-Heine University, Duesseldorf	N/A
Completed	HeartMate PHP™ CE Mark Clinical Investigation Plan NCT02156609	Abbott Medical Devices	N/A